Navigation Links
MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
Date:9/11/2007

rm using the effective interest method.

The foreign exchange gains and losses were nominal for each of Q1/08 and Q1/07.

Liquidity and Capital Resources

As of July 31, 2007, the Company had cash, cash equivalents and short-term investments of $12.8 million (April 30, 2007: $15.3 million) and the Company's net working capital was $12.1 million (April 30, 2007: $14.6 million). The $2.5 million decrease in net working capital from April 30, 2007 is primarily attributable to the cash loss of $2.4 million (loss excluding non-cash expenses: amortization, stock-based compensation and accretion of the convertible royalty participation units) for the three months ended July 31, 2007.

MIGENIX believes that its funds on hand at July 31, 2007, together with ongoing cost containment measures and expected interest income, are sufficient to provide for operations into the third quarter of calendar 2008 before funds received, if any, from existing or new license agreements, the exercise of warrants and options and future financing activities. The Company will continue advancing its highest priority programs while operating within an annual burn rate of $11 million to $13 million. The magnitude of spending in the Company's development programs will be dependent on the licensing status of the celgosivir program and results in the programs, and we may need to increase or decrease our annual burn rate in response to such results. MIGENIX is likely to need to raise additional funds in support of its operations and there is no assurance that such funds can be obtained

Outstanding Shares

There are currently 94,463,806 (July 31, 2007: 94,463,806; April 30, 2007: 94,237,205) common shares outstanding; 29,465 convertible royalty participation units (July 31, 2007 and April 30, 2007: 29,465); and 9,250,000 (July 31, 2007: 9,250,000; April 30, 2007: 9,350,000) preferred shares outstanding. In May 2007 the Company converted 50,000 Series A and 50,000 Series B
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... SAN FRANCISCO , July 30, 2014 /PRNewswire/ ... Transplant Congress evaluated the safety and efficacy of ... antibody-mediated rejection following kidney transplants in highly sensitized ... important inhibitor of the complement system. ... results in significant increases in the levels of ...
(Date:7/30/2014)... 2014 While administrative claims and ... research for a relatively long period of time, ... the use of these ‘big data’ for comparisons ... combining today’s powerful computer technology with the plethora ... data’ holds significant promise for identifying optimal interventions ...
(Date:7/30/2014)... 30, 2014   Wyle has been ... Lifecycle Mission Support Services (FILMSS) contract awarded by ... the terms of the contract, Wyle will provide ... Field, Calif. In particular, Wyle will provide program ... projects on the International Space Station and collaborative ...
(Date:7/30/2014)... BCC Research ( http://www.bccresearch.com ) reveals in ... Industrial Applications , the global market for industrial enzymes ... 2018, registering a five-year compound annual growth rate (CAGR) ... in the detergent enzyme segment with a CAGR of ... influenced almost every sector of industrial activity, ranging from ...
Breaking Biology Technology:Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3Leveraging ‘Big Data’ - Methodological Considerations in Health Services Research, New Webinar Hosted by Xtalks 2Wyle Wins NASA's Fully Integrated Lifecycle Mission Support Services Contract 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3
... 2012 Sofie Biosciences, Inc. , offering a comprehensive ... PET molecular imaging probes to better understand human disease, has ... by the United States Patent Office on technology that has ... of novel PET probes, known as [18F]FAC. Positron ...
... VA -- This time of year parents in northern ... activities. In addition to layers of warm clothing, gloves, ... available to mitigate the potential hazards of winter sports ... protect children,s heads from the stresses and forces that ...
... as it turns out, largely transparent to water. ... Polytechnic Institute (RPI) has determined that gold, copper and silicon ... layer of graphene as they would without. The research, ... Materials , is significant for scientists learning to fine-tune surface ...
Cached Biology Technology:Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology 2Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology 3How well does protective headgear work for small children engaged in Winter activities? 2Water sees right through graphene 2
(Date:7/30/2014)... stem cells can develop into a multitude of cells types. ... into the specific types of mature cells that make up ... One key seems to be long chains of sugars that ... group at the University of California, San Diego, has created ... but can be more easily manipulated to direct the process, ...
(Date:7/30/2014)... July 30, 2014 The Nano-Bio Manufacturing ... States Air Force Research Laboratory (AFRL), has awarded ... Binghamton University to develop electronics and ... The $425,000 project, with contributions from the University ... Electronics, Inc. ( Endicott, N.Y. ), ...
(Date:7/30/2014)... a paper published online today in the journal ... researchers Evan Kodra and Auroop Ganguly found that while ... variability in temperature extremes. For instance, while each year,s ... averages will also tend to fall within a wider ... are currently being observed. This means that even as ...
Breaking Biology News(10 mins):Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 2Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 3Big data confirms climate extremes are here to stay 2
... in common with mustard except hotdogs. Yet based on ... scientists have discovered a possible explanation for how organisms, ... the growth of organs. These findings overturn conventional views ... light on the development of more productive plants and ...
... and engineers in Antarctica, funded by the National Science Foundation ... past climate and greenhouse gases in the atmosphere that extends ... Sheet (WAIS), the ice containing the record is known as ... make up the core contain uniquely detailed information on past ...
... from Indiana University and Brown University believes it has ... and nuclear DNA produce an incompatible genotype that reduces ... The new research, led by IU biologists Kristi ... researcher Mo Siddiq, describes the cause and consequences of ...
Cached Biology News:Plants cut the mustard for basic discoveries in metabolism 2Plants cut the mustard for basic discoveries in metabolism 3Antarctic ice core contains unrivaled detail of past climate 2Antarctic ice core contains unrivaled detail of past climate 3Biologists map rare case of fitness-reducing interaction in nuclear, mitochondrial DNA 2
... Chemicon's 3243 provides all the materials necessary ... use in CMV antigen studies analysis. Kit ... - (Catalog No. 5122) One bottle containing 220 ... Fixation Solution (5X) - (Catalog No. 5113) ...
ANTI NO-TRYPTOPHAN CONJUGATE...
GOAT ANTI SLI...
ANTI L-DOPA...
Biology Products: